Label Changes for:
Bepreve (bepotastine besilate) 1.5% ophthalmic solution
June 2012
Changes have been made to the CONTRAINDICATIONS and ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – June 2012

